Bioblast Pharma Ltd (ORPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ORPN | XBIO | INDP | ||
| Company | Bioblast Pharma Ltd | Xenetic Biosciences Inc | Indaptus Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.82 | 2.16 | 2.60 | ||
| High | 11.50 | 2.17 | 2.75 | ||
| Low | 10.32 | 2.01 | 2.40 | ||
| Latest | 11.50 | 2.08 | 2.55 | ||
| Change | +0.72 | -0.12 | -0.10 | ||
| % Change | +6.68% | -5.45% | -3.77% | ||
| Volume | 19,700 | 53,900 | 919,200 | ||
| 20-Day Average Volume | 25,821 | 35,860 | 1,722,685 | ||
| Previous Close | 10.78 | 2.20 | 2.65 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 11.19 | 2.33 | 2.29 | ||
| 20-Day Raw Stochastic | 31.30% | 21.93% | 51.08% | ||
| 20-Day Relative Strength | 53.88 | 39.03 | 50.06 | ||
| Weighted Alpha | -18.50 | -68.24 | -84.93 | ||
| Today's Opinion | 56% Buy | 88% Sell | 80% Sell | ||
| Previous Opinion | 40% Buy | 88% Sell | 80% Sell | ||
| Last Month's Opinion | 8% Sell | 40% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.28% since 03/18/19 | +0.97% since 12/18/25 | +20.85% since 12/18/25 | ||
| Low | 10.32 on 03/25/19 | 2.01 on 12/26/25 | 1.92 on 12/23/25 | ||
| High | 11.74 on 03/21/19 | 2.29 on 12/22/25 | 3.15 on 12/24/25 | ||
| 1-Month | |||||
| %Chg | +5.70% since 02/25/19 | -19.38% since 11/26/25 | +14.35% since 11/26/25 | ||
| Low | 9.45 on 03/06/19 | 1.90 on 12/16/25 | 1.92 on 12/23/25 | ||
| High | 16.00 on 03/07/19 | 2.72 on 11/28/25 | 3.15 on 12/24/25 | ||
| 3-Month | |||||
| %Chg | +63.35% since 12/24/18 | -32.90% since 09/26/25 | -26.93% since 09/26/25 | ||
| Low | 6.16 on 12/31/18 | 1.90 on 12/16/25 | 1.65 on 11/21/25 | ||
| High | 17.36 on 02/19/19 | 13.93 on 10/08/25 | 5.25 on 10/09/25 | ||
| 6-Month | |||||
| %Chg | +6.09% since 09/25/18 | -47.87% since 06/26/25 | -80.16% since 06/26/25 | ||
| Low | 6.16 on 12/31/18 | 1.90 on 12/16/25 | 1.65 on 11/21/25 | ||
| High | 18.40 on 10/18/18 | 13.93 on 10/08/25 | 13.40 on 07/10/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,805 | 5,040 | 4,641 | ||
| Shares Outstanding, K | 418 | 2,291 | 1,751 | ||
| Annual Sales | 0 | 2,500,000 | 0 | ||
| Annual Net Income | -5,950,000 | -3,960,000 | -15,020,000 | ||
| Last Quarter Sales | N/A | 1,030,000 | 0 | ||
| Last Quarter Net Income | N/A | -510,000 | -2,980,000 | ||
| 60-Month Beta | 1.41 | 2.40 | 1.02 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.33 on 11/12/25 | -2.98 on 11/12/25 | ||
| Latest Earnings Date | 04/22/19 | 03/17/26 | 03/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||